High Sam68 expression predicts poor prognosis in non-small cell lung cancer

被引:0
作者
Z. Zhang
Y. Xu
N. Sun
M. Zhang
J. Xie
Z. Jiang
机构
[1] Qianfoshan Hospital Affiliated to Shandong University,Department of Critical
来源
Clinical and Translational Oncology | 2014年 / 16卷
关键词
Sam68; Non-small cell lung cancer; Prognosis; Biomarker;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:886 / 891
页数:5
相关论文
共 111 条
[1]  
Subramaniam S(2013)Lung cancer biomarkers: state of the art J Carcinog 12 3-1774
[2]  
Thakur RK(2010)Staging of non-small cell lung cancer (NSCLC): a review Respir Med 104 1767-755
[3]  
Yadav VK(2009)Pharmacogenomics of platinum-based chemotherapy in NSCLC Expert Opin Drug Metab Toxicol 5 745-614
[4]  
Nanda R(2010)Chemotherapy: effectiveness of adjuvant chemotherapy for resected NSCLC Nat Rev Clin Oncol 7 613-1819
[5]  
Chowdhury S(2008)Multiple end-point analysis reveals cisplatin damage tolerance to be a chemoresistance mechanism in a NSCLC model: implications for predictive testing Int J Cancer 122 1810-363
[6]  
Agrawal A(2011)Predictive markers in the adjuvant therapy of non-small cell lung cancer Lung Cancer 74 355-86
[7]  
Tsim S(2003)Sam68, the KH domain-containing superSTAR Biochim Biophys Acta 13 73-871
[8]  
O’Dowd CA(1994)An RNA-binding protein associated with Src through its SH2 and SH3 domains in mitosis Nature 368 867-874
[9]  
Milroy R(1994)A target for Src in mitosis Nature 13 871-R102
[10]  
Davidson S(2011)The RNA-binding protein Sam68 is a multifunctional player in human cancer Endocr Relat Cancer 13 R91-4964